- Home
- KRNT vs TERN Comparison
KRNT vs TERN Comparison
Compare KRNT & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRNT
- TERN
- Stock Information
- Founded
- KRNT 2002
- TERN 2017
- Country
- KRNT Israel
- TERN United States
- Employees
- KRNT N/A
- TERN N/A
- Industry
- KRNT Industrial Machinery/Components
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- KRNT Industrials
- TERN Health Care
- Exchange
- KRNT Nasdaq
- TERN Nasdaq
- Market Cap
- KRNT 686.7M
- TERN 634.5M
- IPO Year
- KRNT 2015
- TERN 2021
- Fundamental
- Price
- KRNT $14.83
- TERN $8.18
- Analyst Decision
- KRNT Strong Buy
- TERN Buy
- Analyst Count
- KRNT 5
- TERN 6
- Target Price
- KRNT $31.40
- TERN $13.99
- AVG Volume (30 Days)
- KRNT 369.7K
- TERN 1.1M
- Earning Date
- KRNT 11-05-2025
- TERN 11-11-2025
- Dividend Yield
- KRNT N/A
- TERN N/A
- EPS Growth
- KRNT N/A
- TERN N/A
- EPS
- KRNT N/A
- TERN N/A
- Revenue
- KRNT $207,639,000.00
- TERN N/A
- Revenue This Year
- KRNT $5.50
- TERN N/A
- Revenue Next Year
- KRNT $9.04
- TERN N/A
- P/E Ratio
- KRNT N/A
- TERN N/A
- Revenue Growth
- KRNT N/A
- TERN N/A
- 52 Week Low
- KRNT $12.78
- TERN $1.87
- 52 Week High
- KRNT $34.29
- TERN $10.70
- Technical
- Relative Strength Index (RSI)
- KRNT 43.46
- TERN 68.53
- Support Level
- KRNT $14.10
- TERN $7.01
- Resistance Level
- KRNT $15.53
- TERN $7.67
- Average True Range (ATR)
- KRNT 0.56
- TERN 0.46
- MACD
- KRNT 0.12
- TERN -0.00
- Stochastic Oscillator
- KRNT 51.39
- TERN 97.22
About KRNT Kornit Digital Ltd.
Kornit Digital Ltd develops, designs and markets digital printing solutions for the world-wide printed textile industry. The company focuses on its DTG and DTF segments of the printed textile industry. Its solutions include digital printing systems, ink and other consumables, associated software and value-added services that allow for large-scale printing of short runs of complex images and designs directly on finished garments and fabrics. It generates revenue from sales of systems, ink and other consumables and service including software subscriptions The company geographically operates in U.S., EMEA, Asia Pacific and other countries. It derives maximum revenue from U.S.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.